Cardiac Involvement in Neurosarcoidosis.
Sama Noroozi GilandehiKa-Ho WongTrieste FrancisMelissa A WrightJennifer LordJosef StehlikLine KemeyouTammy SmithStacey L ClardyPublished in: Neurology(R) neuroimmunology & neuroinflammation (2024)
In this cohort, 12% of patients with NS also had confirmed CS. In addition, these patients had a high burden of cardiovascular disease not directly attributed to sarcoidosis. Our data suggest that patients with NS require comprehensive cardiac evaluation. Future studies are needed to clarify the extent of the direct contribution of granulomatous inflammation on the cardiovascular system from the indirect contribution of treatments such as glucocorticoids that lead to increased risk of cardiovascular disease in sarcoidosis.
Keyphrases
- cardiovascular disease
- end stage renal disease
- newly diagnosed
- ejection fraction
- left ventricular
- type diabetes
- chronic kidney disease
- oxidative stress
- peritoneal dialysis
- electronic health record
- cardiovascular risk factors
- coronary artery disease
- risk factors
- atrial fibrillation
- cardiovascular events
- systemic sclerosis
- idiopathic pulmonary fibrosis
- data analysis